Clinical trials
Phase 3 Cytokine Release Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 9 |
| 2021 | 2 |
| 2022 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 5 |
| Terminated | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexandria University | 2 |
| Novartis Pharmaceuticals | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beneficência Portuguesa de São Paulo | 1 |
| Bioxytran Inc. | 1 |
| Centre Hospitalier St Anne | 1 |
| Emory University | 1 |
| Humanigen, Inc. | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Incyte Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cytokine Release Syndrome | 14 |
| COVID-19 | 11 |
| Pneumonia | 6 |
| Respiratory Distress Syndrome | 3 |
| Coronavirus Infections | 1 |
| Lymphohistiocytosis, Hemophagocytic | 1 |
| Pulmonary Fibrosis | 1 |
| Severe Acute Respiratory Syndrome | 1 |
Trials
Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.